Skip to main content
Search
Menu
Laboratory development activities
Photo: RISE

Pharmaceutical manufacturing without chlorinated solvents

The project aims to replace chlorinated solvents, which are unsuitable from both sustainability and health aspects, in a critical step of the manufacturing process of the active pharmaceutical ingredient vipoglanstat.

The process step, which has proven problematic, is crucial for controlling the level of contaminants in the final product and the process yield has a significant effect on the amount of chemicals and solvents required in the preceding manufacturing steps.

The project is expected to lead to an increased understanding of how critical impurities are formed in the process and how they can be reduced. Similarly, the project will lead to an increased understanding of the parameters that affect crystallisation and thus enable the development of a robust and efficient process in terms of both yield and quality without, as today, using chlorinated solvents.

Summary

Project name

Crystallisation of pharmaceuticals

Status

Active

Region

Region Stockholm

RISE role in project

Coordinator

Project start

Duration

1 år

Total budget

1 MSEK

Funders

Vinnova

Coordinators

Project members

Supports the UN sustainability goals

3. Good health and well-being

Contact person

Vahak Abedi

Forskare/Projektledare

+46 10 516 65 49

Read more about Vahak

Contact Vahak
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

* Mandatory By submitting the form, RISE will process your personal data.

Contact person

Esmail Yousefi

Enhetschef

+46 10 516 65 90

Read more about Esmail

Contact Esmail
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

* Mandatory By submitting the form, RISE will process your personal data.